1. Home
  2. LUNR vs VRDN Comparison

LUNR vs VRDN Comparison

Compare LUNR & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNR
  • VRDN
  • Stock Information
  • Founded
  • LUNR 2013
  • VRDN 2006
  • Country
  • LUNR United States
  • VRDN United States
  • Employees
  • LUNR N/A
  • VRDN N/A
  • Industry
  • LUNR Industrial Machinery/Components
  • VRDN Medical Specialities
  • Sector
  • LUNR Industrials
  • VRDN Health Care
  • Exchange
  • LUNR Nasdaq
  • VRDN Nasdaq
  • Market Cap
  • LUNR 1.3B
  • VRDN 1.3B
  • IPO Year
  • LUNR N/A
  • VRDN N/A
  • Fundamental
  • Price
  • LUNR $11.36
  • VRDN $14.34
  • Analyst Decision
  • LUNR Buy
  • VRDN Strong Buy
  • Analyst Count
  • LUNR 7
  • VRDN 11
  • Target Price
  • LUNR $15.21
  • VRDN $38.50
  • AVG Volume (30 Days)
  • LUNR 6.0M
  • VRDN 686.9K
  • Earning Date
  • LUNR 08-12-2025
  • VRDN 08-07-2025
  • Dividend Yield
  • LUNR N/A
  • VRDN N/A
  • EPS Growth
  • LUNR N/A
  • VRDN N/A
  • EPS
  • LUNR N/A
  • VRDN N/A
  • Revenue
  • LUNR $217,305,000.00
  • VRDN $302,000.00
  • Revenue This Year
  • LUNR $20.66
  • VRDN N/A
  • Revenue Next Year
  • LUNR $45.85
  • VRDN $17,102.33
  • P/E Ratio
  • LUNR N/A
  • VRDN N/A
  • Revenue Growth
  • LUNR 61.52
  • VRDN 4.86
  • 52 Week Low
  • LUNR $3.15
  • VRDN $9.90
  • 52 Week High
  • LUNR $24.95
  • VRDN $27.20
  • Technical
  • Relative Strength Index (RSI)
  • LUNR 56.58
  • VRDN 50.32
  • Support Level
  • LUNR $9.52
  • VRDN $14.11
  • Resistance Level
  • LUNR $10.54
  • VRDN $16.05
  • Average True Range (ATR)
  • LUNR 0.68
  • VRDN 0.74
  • MACD
  • LUNR -0.09
  • VRDN -0.13
  • Stochastic Oscillator
  • LUNR 70.23
  • VRDN 20.18

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: